While reporting financial results for the fourth quarter on Tuesday, biopharmaceutical company Merck & Co., Inc. (MRK), known as MSD ...
Highlights Launched Vision 2030Delivered Adjusted EBITDA margin of 19.1%Returned to positive packaging volume growth in second half of the yearAchieved Innovation Sales Growth of $205 millionExecuted ...
Worldwide Sales Were $15.6 Billion, an Increase of 7% From Fourth Quarter 2023; Excluding the Impact of Foreign Exchange, ...